Aberdeen Group
IDYA icon

Aberdeen Group’s IDEAYA Biosciences IDYA Stock Holding History

Aberdeen Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.9M Buy
560,934
+15,303
+3% +$468K 0.03% 430
2026
Q1 		$18.2M Sell
545,631
-14,992
-3% -$503K 0.03% 452
2025
Q4 		$19.4M Buy
560,623
+2,575
+0.5% +$82.1K 0.03% 441
2025
Q3 		$15.2M Buy
558,048
+116,743
+26% +$2.82M 0.02% 522
2025
Q2 		$9.28M Hold
441,305
– – 0.02% 614
2025
Q1 		$7.23M Buy
441,305
+134,582
+44% +$2.87M 0.01% 633
2024
Q4 		$7.88M Buy
306,723
+73,893
+32% +$2.09M 0.01% 556
2024
Q3 		$7.38M Buy
+232,830
New +$8.83M 0.01% 579
2021
Q1 		– Sell
-13,320
Closed -$201K – 994
2020
Q4 		$201K Buy
+13,320
New +$180K ﹤0.01% 944

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Aberdeen Group's IDYA Position: Q2 2026 in Review

Aberdeen Group increased its IDEAYA Biosciences (IDYA) stake by 2.8% in Q2 2026, buying an estimated $468K and bringing the position to 560,934 shares worth $20.9M. The position accounts for 0.03% of the portfolio, ranked #430.

Aberdeen Group first reported a position in IDYA in Q4 2020 and has held it in 9 quarters since. 286 funds tracked by Wall St. Rank hold IDYA as of Q2 2026.

  • Aberdeen Group held 560,934 shares of IDEAYA Biosciences worth $20.9M as of Q2 2026.
  • Aberdeen Group bought 15,303 IDEAYA Biosciences shares in Q2 2026, an estimated $468K.
  • IDEAYA Biosciences made up 0.03% of Aberdeen Group's portfolio in Q2 2026, its #430 holding.
  • Aberdeen Group first reported a position in IDEAYA Biosciences in Q4 2020 and has held it in 9 quarters since.
  • 286 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q2 2026.

Based on Aberdeen Group's 13F filing for Q2 2026, filed 31 Jul 2026.